Skip to main content
letter
. 2024 Dec 3;48:101164. doi: 10.1016/j.lanepe.2024.101164

Table 1.

Key recommendations regarding implementation of digital adherence technologies in Europe from COST Action ENABLE.

Acknowledge
  • Around 50% of medication is not taken as prescribed

  • Medication non-adherence is associated with an estimated 200,000 deaths and a financial burden of €125 billion annually in Europe

  • Enhancing medication adherence improves clinical outcomes, while reducing the financial and environmental burden on health systems

Inform
  • Adoption of digital technologies can effectively support medication adherence and improve patients’ health outcomes

  • Innovative digital technologies foster communication and collaboration among healthcare professionals and patients, and should be made more accessible

Incentivise
  • Increased investment and incentives to accelerate sustainable, cost-effective implementation of digital adherence technologies in health systems are necessary

  • Digital adherence technology should be an integral part of clinical trials to support efficient drug development

Steer & support
  • Data-driven European strategies to improve medication adherence are essential

  • Reimbursement of effective digital adherence technology is critical to unlock their full potential of making health systems more efficient